Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000899243-19-018910)

Filing Details

Accession Number:
0000899243-19-018910
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-02 17:13:21
Reporting Period:
2019-07-02
Accepted Time:
2019-07-02 17:13:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219042 Robert Nelsen 8755 W. Higgins Road, Suite 1025
Chicago IL 60631		 Yes No Yes No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-02 723,644 $0.00 724 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-07-02 723,643 $0.00 724 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-07-02 857,793 $0.00 1,581,437 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-07-02 857,792 $0.00 1,581,435 No 4 C Indirect See Footnote
Common Stock Acquisiton 2019-07-02 100,000 $16.00 1,681,437 No 4 P Indirect See Footnote
Common Stock Acquisiton 2019-07-02 100,000 $16.00 1,681,435 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-07-02 557,207 $0.00 723,644 $0.00
Common Stock Series A Preferred Stock Disposition 2019-07-02 557,206 $0.00 723,643 $0.00
Common Stock Series A Preferred Stock Disposition 2019-07-02 660,502 $0.00 857,793 $0.00
Common Stock Series A Preferred Stock Disposition 2019-07-02 660,501 $0.00 857,792 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series A Preferred Stock is convertible on a 1.2987-for-one basis into the number of shares of Common Stock shown in Column 3. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock will convert into shares of Common Stock of the Issuer. The Series A Preferred Stock has no expiration date.
  2. These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, L.P. , the sole general partner of ARCH IX, and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
  3. The Series B Preferred Stock is convertible on a 1.2987-for-one basis into the number of shares of Common Stock shown in Column 3. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock will convert into shares of Common Stock of the Issuer. The Series B Preferred Stock has no expiration date.
  4. These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX Overage, L.P., the sole general partner of ARCH Overage, and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.